From: Dr. PIAS: an integrative system for assessing the druggability of protein-protein interactions
Information | Source(s) or program(s) used |
---|---|
Structural information | Â |
   Tertiary structures | |
   Pockets on PPI interface | [25] |
Volume | |
Accessible surface area | |
Compactness | [6] |
Planarity | [6] |
Narrowness | [6] |
Curvature | [26] |
Roughness | [26] |
Amino acid composition | |
   Domains | |
   Disordered regions | [37] |
   Amino acid sequence motifs | |
Drug/chemical information | Â |
   FDA-approved drugs | [40] |
   Chemicals associated with interacting proteins | [41] |
Functional information | Â |
   Human diseases in OMIM | [42] |
   Number of interacting proteins in PPI network | [6] |
   Biological pathways | |
   GO terms and identity scores of GO terms | |
   Gene expression profiles and similarity scores of profiles | |
   Paralogs |